Wednesday, January 18, 2023 Daily Archives

Catalent and Avantor ink multi-year supply and services deal

Avantor will supply Catalent with clinical and production materials, services, and laboratory supplies. Avantor, a company that provides products and services to clients in the life sciences space, has entered into a multi-year supply and services agreement with contract development manufacturing organization (CDMO) Catalent. No financial details of the deal are being disclosed but the partnership will see Catalent work with Avantor across more than 50 facilities situated across the globe. “Avantor is an existing supplier to Catalent,” a spokesperson…

10 CGT approvals in 2022 brings ‘Gottlieb’s math’ close to realization

With cell and gene therapies coming of age, experts at Advanced Therapies Week looked to reducing COGs, novel payer models, and even biosimilars to tackle their spiraling price tags. In 2022, there were 10 approvals between the US and Europe for nine cell and gene therapy products: Adstiladrin, Breyanzi, Carvykti, Ebvallo, Hemgenix (approved by both FDA and EMA), Roctavian, Skysona, Upstaza, Zynteglo. As such, optimism was high at Phacilitate’s Advanced Therapies Week, held this week in Miami, Florida. “We’ve gone…